The MCP-1-CCR2 pathway is also up-regulated in the livers of animals with NASH and is thus critical to the development of hepatic steatosis and fibrosis by promoting the migration of hepatic stellate cells [59,60]. Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.